Iterum Therapeutics Plc Q4 Loss Decreases, Beats Estimates

Iterum Therapeutics plc (ITRM) released Loss for fourth quarter that decreased from the same period last year and beat the Street estimates.

The company's earnings totaled -$6.58 million, or -$0.25 per share. This compares with -$12.36 million, or -$0.94 per share, last year.

Excluding items, Iterum Therapeutics plc reported adjusted earnings of -$3.14 million or -$0.12 per share for the period.

Analysts on average had expected the company to earn -$0.24 per share. Analysts' estimates typically exclude special items.

Iterum Therapeutics plc earnings at a glance (GAAP) :

-Earnings: -$6.58 Mln. vs. -$12.36 Mln. last year.
-EPS: -$0.25 vs. -$0.94 last year.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com